Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | PTOV1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
mRNA | GLTSCR2 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | C21orf58 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | CEP68 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
mRNA | MARCKSL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |